Anebulo Pharmaceuticals, Inc.Anebulo Pharmaceuticals, Inc.Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc.

No trades
See on Supercharts

ANEB fundamentals

An in-depth look to Anebulo Pharmaceuticals, Inc. operating, investing, and financing activities

ANEB free cash flow for Q1 25 is -1.69 M USD. For 2024, ANEB free cash flow was -8.09 M USD and operating cash flow was -8.09 M USD.

Q4 '20
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '20
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM
Free cash flowYoY growth